Clinical Trial Update: A Study to go Back Into Records and Observe How People With Metastatic Renal Cell Carcinoma (mRCC) Who Received a Medicine Called Sunitinib Responded to This Medicine.

View source ↗

Summary

This clinical trial update summarizes outcomes observed in patients with metastatic renal cell carcinoma treated with sunitinib, based on retrospective record r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma
• Renal Cell Carcinoma

Drugs mentioned

• Sutent (sunitinib)

Snippet

Sponsor: Pfizer | Conditions: Carcinoma, Renal Cell, Clear-cell Metastatic Renal Cell Carcinoma | Status: COMPLETED | Results posted: 2024-08-05